Relationship between Retinal Microvasculature, Cardiovascular Risk and Silent Brain Infarction in Hypertensive Patients

Objective: The aims of this study are to analyze the role of artery-vein ratio AVR assessment using VesselMap 2 software (Imedos Systems) and cardiovascular risk evaluation by means of REGICOR in the prediction of silent brain infarction (SBI) in middle-age hypertensive patients from the ISSYS study...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostics (Basel) 2021-05, Vol.11 (6), p.937
Main Authors: Forés, Rosa, Manresa, Josep M., López-Lifante, Victor M., Heras, Antonio, Delgado, Pilar, Vázquez, Xose, Ruiz, Susana, Alzamora, Maria Teresa, Toran, Pere
Format: Article
Language:English
Subjects:
Age
Blood pressure
Cardiovascular disease
cardiovascular risk
Cholesterol
Dementia
Diabetes
Diabetic retinopathy
Hypertension
Kidney diseases
Magnetic resonance imaging
Population
Primary care
Regression analysis
retinal microvasculature
silent brain infarction
Software
Stroke
Variables
Veins & arteries
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: The aims of this study are to analyze the role of artery-vein ratio AVR assessment using VesselMap 2 software (Imedos Systems) and cardiovascular risk evaluation by means of REGICOR in the prediction of silent brain infarction (SBI) in middle-age hypertensive patients from the ISSYS study. Material and Methods: A cross-sectional study with 695 patients with hypertension aged 50 to 70 years who participated in the project Investigating Silent Strokes in HYpertensives: a Magnetic Resonance Imaging Study (ISSYS), was conducted in two Primary Care Centres of Barcelona. Participants agreed to a retinography and an MRI to detect silent brain infarction (SBI). The IMEDOS software was used for the semiautomatic caliber measurement of retinal arteries and veins, and the AVR was considered abnormal when
ISSN:2075-4418
2075-4418
DOI:10.3390/diagnostics11060937